IGF1 and prostate carcinoma: demonstrated that insulin resistance is associated with such as hyperinsulinemia (48), IGF levels (19, 20), and Phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathways (49), which may play an important role in the development of prostate cancer.